Filing Flows › Biotricity (BTCY) › Technology Fees revenue
Biotricity (BTCY) Technology Fees revenue by quarter
Biotricity's Technology Fees revenue was $4.2M in Q1 FY27 (first quarter fiscal 2027), +6% from Q4 FY26. Over the last 7 quarters it ranged from $3.1M (Q4 FY25) to $4.2M (Q1 FY27).
| Quarter | Technology Fees revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q1 FY27 | $4.2M | +6% | +24% |
| Q4 FY26 | $3.9M | +8% | +26% |
| Q3 FY26 | $3.6M | +4% | +7% |
| Q2 FY26 | $3.5M | +4% | — |
| Q1 FY26 | $3.4M | +8% | — |
| Q4 FY25 | $3.1M | -8% | — |
| Q3 FY25 | $3.4M | — | — |
Q1 FY27 at a glance
Biotricity, Q1 FY27: revenue $4.3M (+10% year over year), operating margin 3.7%, net loss $959K, operating cash flow $507K. The chart follows the revenue to costs, profit and cash.
Questions
What is Biotricity's Technology Fees revenue?
Biotricity's Technology Fees revenue was $4.2M in Q1 FY27 (first quarter fiscal 2027), +6% from Q4 FY26.
How has Biotricity's Technology Fees revenue changed?
Over the last 7 quarters it ranged from $3.1M (Q4 FY25) to $4.2M (Q1 FY27).